Document is current
Any future updates will be listed below
-
Authors
Maass, Kendra K. https://orcid.org/0000-0001-9357-5038
Puranachot, Pitithat
Volz, Stefanie
Schad, Paulina S.
Finster, Agnes M.E.
Fischer, Tom T.
Jones, Barbara C.
Schramm, Kathrin
Henneken, Sophie C.
Simon, Nike
Montigel, Sophia H.
Wedig, Tatjana
Schwarz, Nathalie
Zuliani, Cecilia
Fiesel, Petra
Previti, Christopher
Balasubramanian, Gnanaprakash
Iser, Florian
Meyer, Jochen
van Tilburg, Cornelis M.
Milde, Till
Witt, Olaf
Rossi, Corinne
Sparber-Sauer, Monika
Zimmermann, Stefanie
Lehrnbecher, Thomas
Lauten, Melchior
Sill, Martin
Jäger, Natalie
Autry, Robert J.
Northcott, Paul A.
Sahm, Felix
Jones, David T.W.
Pfister, Stefan M.
Brors, Benedikt
Pajtler, Kristian W.
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 17 February 2026
Accepted: 16 July 2026
First Online: 27 July 2026
Declarations
Ethics approval and consent to participate: The INFORM registry is a prospective, multicenter study registered at the German Clinical Trial Register (DRKS00007623). Ethics approval was obtained from the Ethics Committee of Heidelberg University (S-502/2013; S-795/2020), and written informed consent was obtained from all participants or their legal guardians. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Additional pediatric control data were obtained from the European Genome-phenome Archive (EGAD00001007080) [ ].
Consent for publication: Not applicable, as the manuscript does not contain any identifiable individual person’s data.
Competing interests: Felix Sahm is Co-founder and shareholder of Heidelberg Epignostix GmbH. All other authors declare no competing interests.
